133 related articles for article (PubMed ID: 19878975)
21. In vitro characterisation of two naturally occurring mutations in the thrombin-sensitive region of anticoagulant protein S.
Giri TK; de Frutos PG; Yamazaki T; Villoutreix BO; Dahlbäck B
Thromb Haemost; 1999 Dec; 82(6):1627-33. PubMed ID: 10613646
[TBL] [Abstract][Full Text] [Related]
22. [Protein C, protein S and heparin cofactor II--their significance as the regulatory factors in the blood coagulation cascade].
Shinmyozu K
Rinsho Byori; 1994 Jan; 42(1):9-15. PubMed ID: 8107289
[TBL] [Abstract][Full Text] [Related]
23. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function.
He X; Shen L; Villoutreix BO; Dahlbäck B
J Biol Chem; 1998 Oct; 273(42):27449-58. PubMed ID: 9765274
[TBL] [Abstract][Full Text] [Related]
24. The impact of the inflammatory response on coagulation.
Esmon CT
Thromb Res; 2004; 114(5-6):321-7. PubMed ID: 15507261
[TBL] [Abstract][Full Text] [Related]
25. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
Geng JP; Castellino FJ
Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
[TBL] [Abstract][Full Text] [Related]
26. Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals.
Heeb MJ; Koenen RR; Fernández JA; Hackeng TM
J Thromb Haemost; 2004 Oct; 2(10):1766-73. PubMed ID: 15456488
[TBL] [Abstract][Full Text] [Related]
27. EGF-like module pair 3-4 in vitamin K-dependent protein S: modulation of calcium affinity of module 4 by module 3, and interaction with factor X.
Stenberg Y; Muranyi A; Steen C; Thulin E; Drakenberg T; Stenflo J
J Mol Biol; 1999 Oct; 293(3):653-65. PubMed ID: 10543957
[TBL] [Abstract][Full Text] [Related]
28. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen.
Giri TK; Hillarp A; Härdig Y; Zöller B; Dahlbäck B
Thromb Haemost; 1998 Apr; 79(4):767-72. PubMed ID: 9569190
[TBL] [Abstract][Full Text] [Related]
29. The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities.
Koenen RR; Gomes L; Tans G; Rosing J; Hackeng TM
Thromb Haemost; 2004 Jun; 91(6):1105-14. PubMed ID: 15175796
[TBL] [Abstract][Full Text] [Related]
30. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
Villoutreix BO; Dahlbäck B
Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
[TBL] [Abstract][Full Text] [Related]
31. The hydrophobic nature of residue-5 of human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles.
Jalbert LR; Chan JC; Christiansen WT; Castellino FJ
Biochemistry; 1996 Jun; 35(22):7093-9. PubMed ID: 8679535
[TBL] [Abstract][Full Text] [Related]
32. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH
Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573
[TBL] [Abstract][Full Text] [Related]
33. The gamma-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding.
Saller F; Villoutreix BO; Amelot A; Kaabache T; Le Bonniec BF; Aiach M; Gandrille S; Borgel D
Blood; 2005 Jan; 105(1):122-30. PubMed ID: 15308562
[TBL] [Abstract][Full Text] [Related]
34. Protein S.
Hepner M; Karlaftis V
Methods Mol Biol; 2013; 992():373-81. PubMed ID: 23546730
[TBL] [Abstract][Full Text] [Related]
35. Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.
Heeb MJ; Prashun D; Griffin JH; Bouma BN
FASEB J; 2009 Jul; 23(7):2244-53. PubMed ID: 19244162
[TBL] [Abstract][Full Text] [Related]
36. Protein S multimers and monomers each have direct anticoagulant activity.
Heeb MJ; Schuck P; Xu X
J Thromb Haemost; 2006 Feb; 4(2):385-91. PubMed ID: 16420570
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of human protein C function by site-directed mutagenesis of the gamma-carboxyglutamic acid domain.
Shen L; Shah AM; Dahlbäck B; Nelsestuen GL
J Biol Chem; 1998 Nov; 273(47):31086-91. PubMed ID: 9813008
[TBL] [Abstract][Full Text] [Related]
38. Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity.
Seré KM; Janssen MP; Willems GM; Tans G; Rosing J; Hackeng TM
Biochemistry; 2001 Jul; 40(30):8852-60. PubMed ID: 11467946
[TBL] [Abstract][Full Text] [Related]
39. Gla domain-mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding.
Sun YH; Shen L; Dahlbäck B
Blood; 2003 Mar; 101(6):2277-84. PubMed ID: 12446455
[TBL] [Abstract][Full Text] [Related]
40. Zn²(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.
Fernandes N; Mosnier LO; Tonnu L; Heeb MJ
J Thromb Haemost; 2010 Sep; 8(9):1976-85. PubMed ID: 20492471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
